News
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
With its purchase of Boston Pharmaceuticals' drug, GSK extends a streak of dealmaking it's undertaken to build a liver ...
Taking semaglutide and liraglutide — a lesser-known active ingredient — medications for weight loss cut their consumption by ...
Liver fibrosis is a gradually worsening condition marked by excessive collagen buildup resulting from ongoing liver damage. This abnormal wound-healing response distorts the liver's structure, ...
14h
Everyday Health on MSNZebound Beats Wegovy for Weight Loss in First Head-to-Head TrialIn a 72-week trial, people taking Zepbound lost 50 pounds on average, compared with about 33 pounds for people taking Wegovy.
Novo Nordisk's current product portfolio is well-protected by patents until at least 2030. Click here to see why NVO stock is ...
When weight loss is equal, though, the GLP-1s seem to provide larger benefits. Researchers say prospective studies are needed ...
Whether it's drawing blood or administering medication, needles scare many people, and not everyone can imagine doing it ...
It seems Novo Nordisk is leaving no stone unturned as it builds a pipeline of drug candidates for obesity and cardiometabolic ...
Throughout her day, the mum-of-one writes down every calorie she eats, a habit borne out of years of weight gain and loss ...
Ozempic side effects are a hot topic but don’t panic – our experts are here to help. Here’s what to expect and how to ...
In SELECT, semaglutide was associated with a 41% reduction in major CV events within 6 months — ie, before weight loss or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results